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Antonio Freyrie, MD, Mauro Gargiulo, MD, and Andrea Stella, MD, Bologna, Italy
Objective: Major postoperative complications such as stroke and myocardial infarction are usually carefully evaluated in
the analysis of carotid revascularization performance. Although transient ischemic attacks (TIAs) are often left unreported,
they also may inﬂuence long-term outcome. The aim of our study was to evaluate the inﬂuence of postoperative TIA in the
long-term survival of patients submitted to carotid revascularization.
Methods: All consecutive patients submitted to either carotid artery stenting or carotid endarterectomy for symptomatic or
asymptomatic carotid stenosis from 2005 to 2012 were retrospectively analyzed. Patients were stratiﬁed according to
their postoperative (30-day) neurologic course (no symptoms, TIA, or stroke). Kaplan-Maier with log-rank analysis was
performed to compare the 5-year survival of patients with postoperative TIA, stroke, or neither; factors affecting the
5-year mortality were evaluated by multivariable Cox proportional hazards models.
Results:Over a total of 1390 carotid revascularizations (carotid endarterectomy, n[ 868 [62.4%]; carotid artery stenting,
n[ 522 [37.6%]), neurological perioperative complications occurred in 67 (4.7%) cases (38, 2.7% TIA; 29, 2.0% stroke).
At 5-year follow-up, overall survival was signiﬁcantly lower in patients with postoperative TIA (78.4 6 8.0% vs 97.4 6
0.6%; P < .001) and postoperative stroke (68.2 6 14.4% vs 97.4 6 0.6%; P [ .03) compared with patients without
neurological complications. By means of multivariate Cox analysis, postoperative TIA and stroke were independent
predictors of decreased survival (hazard ratio [HR], 3.10; 95% conﬁdence interval [CI], 1.01-9.72; P [ .04, and HR,
3.87; 95% CI, 1.13-13.19; P [ .03, respectively), other than age >80 years, postoperative myocardial infarction, and
chronic renal failure (HR, 2.07; 95% CI, 1.41-4.90; P[ .01; HR, 4.33; 95% CI, 2.74-23.79; P[ .04; HR, 2.54; 95% CI,
1.04-6.19; P [ .04, respectively).
Conclusions: TIAs are signiﬁcant events, possibly determined by a wider extent of atherosclerotic disease, with important
effects on long-term mortality similar to that in strokes. Different from most trials evaluating the outcomes of revas-
cularization techniques, the incidence of perioperative TIA should be accurately considered in the analysis. (J Vasc Surg
2014;59:1570-6.)The outcomes of patients undergoing carotid artery
revascularization have been extensively evaluated for both
carotid endarterectomy (CEA) and carotid artery stenting
(CAS) in a variety of clinical studies1,2 and randomized
controlled trials (RCTs)3-6 to evaluate the performance of
the two techniques. Whereas stroke and death are usually
considered as primary end points in most studies, transient
ischemic attacks (TIAs) have been left underreported in
almost all the RCTs.3-6 TIA is deﬁned as a transient ischemic
cerebral event with a complete resolution of the clinical
symptoms within 24 hours, without a permanent organic
impairment.7 Its benign short-term evolution therefore
could be a conceivable reason for consideringTIA as an irrel-
evant postoperative event in the analysis of long-term sur-
vival. In a different way, other types of apparently minor
complicationsdsuch as silentmyocardial infarction detected
only by serological modiﬁcationsdhave been considered inthe Vascular Surgery, University of Bologna
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0the aggregate primary end point of many RCTs5,6 because
of their effects on long-term survival.8 As a matter of fact,
patientswith silentmyocardial infarction havehighermortal-
ity rates (25%) comparedwith patients with no postoperative
cardiac events (7%) at late follow-up (>1 year).8
TIAs have been shown to be independent predictors of
long-term mortality in the general population9; neverthe-
less, their effect on long-term survival in patients submitted
to carotid revascularization has never been speciﬁcally
investigated. Similarly, only few studies evaluated the
impact of postoperative stroke on late survival after carotid
revascularization,10 and data on long-term survival and
disability are available mostly in the general population.11
Thus, we conducted the following study to evaluate if
postoperative TIAs and stroke can affect the long-term sur-
vival of carotid revascularization procedures.METHODS
Study design and setting. Consecutive patients sub-
mitted to carotid revascularization either through CEA or
CAS from January 2005 to December 2012 in a single ac-
ademic center were prospectively entered into a dedicated
database and were retrospectively reviewed. All patients
gave their informed consent for the procedure. The study
was performed according to the rules of the ethics review
board of our institution.
Table I. General characteristics of the population
examined
Clinical characteristics
Mean age 6 SD, years 72.4 6 8.3
Male sex 898 (64.8)
Preoperative neurological symptoms 372 (27.3)
Hypertension 1235 (89.2)
Dyslipidemia 736 (53.2)
Diabetes 386 (27.9)
Smoking 216 (15.6)
Coronary artery disease 421 (30.4)
Chronic obstructive pulmonary disease 227 (16.4)
Chronic renal failure 189 (13.7)
Carotid revascularization techniques
CEA 868 (62.4)
CAS 522 (37.6)
Postoperative (30-day) events
TIA 38 (2.7)
CEA 10 (1.2)a
CAS 28 (5.3)
Stroke 29 (2.0)
CEA 14 (1.6)b
CAS 15 (2.8)
Myocardial infarction 9 (0.6)
CEA 8 (0.9)a
CAS 1 (0.1)
Death 7 (0.5)
CEA 6 (0.6)a
CAS 1 (0.1)
CAS, Carotid artery stenting; CEA, carotid endarterectomy; SD, standard
deviation; TIA, transient ischemic attack.
Data are presented as number (%) unless otherwise indicated.
aP < .05.
bP ¼ NS.
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the long-term survival of patients who had postoperative
TIA, stroke, or had no cerebral event and to evaluate
other factors affecting the long-term survival in patients
submitted to carotid revascularization. The secondary
end point was to compare the long-term survival of pa-
tients with TIA, stroke, or no cerebral events according
to preoperative neurological symptoms (symptomatic vs
asymptomatic).
Patients. Carotid revascularization was performed for
symptomatic carotid artery bifurcation stenosis >50% (ac-
cording to the North American Symptomatic Carotid End-
arterectomy Trial criteria12) and asymptomatic carotid
artery stenosis >60% (according to the North American
Symptomatic Carotid Endarterectomy Trial criteria12).
Clinical characteristics, technical aspects, preoperative
neurologic symptoms, and perioperative (30-day) outcome
were entered into a dedicated database. The clinical charac-
teristics included the following: age; sex; hypertension
(presence of systolic blood pressure >140 or/and diastolic
>90 mm Hg, or speciﬁc therapy); dyslipidemia (total
cholesterol >200 mg/dL or low-density lipoprotein
>120 mg/dL or speciﬁc therapy); diabetes mellitus (pre-
diagnosed in therapy with oral hypoglycemic drugs or
with insulin); current smoking; coronary artery disease
(deﬁned as a history of angina pectoris, myocardial infarc-
tion, or coronary revascularization); chronic obstructive
pulmonary disease (deﬁned as chronic bronchitis or
emphysema); and chronic renal failure (glomerular ﬁltra-
tion rate <60 mL/min). The preoperative neurological
symptoms were evaluated by independent in-hospital neu-
rologists and were deﬁned as TIAs or strokes, occurring in
the past 24 weeks in the hemisphere ipsilateral to the target
carotid stenosis. All patients, both symptomatic and asymp-
tomatic, had a preoperative cerebral computed tomogra-
phy (CT) scan evaluation as a standard procedure before
carotid revascularization, which was performed according
to the Society for Vascular Surgery guidelines13 and sur-
geon preference. Speciﬁcally, patients at high cardiologic
or respiratory risk or with hostile neck were preferentially
submitted to CAS if the preoperative CT angiography
showed a normal arch anatomy.
All CEA procedures were performed by trained
vascular surgeons, under general anesthesia with routine
shunting and patching. Postoperative antiplatelet therapy
was delivered routinely. In patients with appropriate clinical
and anatomical characteristics, CAS was performed by a
single vascular surgeon (G.F.) with an experience of more
than 500 procedures as previously described.14 Brieﬂy,
the patients were taken to the angiographic suite after
providing appropriate informed consent. The patients
were medicated with 100 mg aspirin and 75 mg clopidog-
rel for 3 days before the procedure. All procedures were
performed under local anesthesia and systemic hepariniza-
tion and with an 8F groin introducer. Common carotid
cannulation was achieved by use of 40 (Boston Scientiﬁc,
Natick, Mass) or HS I and II catheters (Medtronic Cardio-
vascular, Santa Rosa, Calif) over a Terumo stiff guide wire(Terumo, Tokyo, Japan). When cannulation could not
be achieved by these means, several different alternative
techniques were used (ie, buddy wire or coaxial).
Brachial or carotid access was not attempted in any
case. Routine cerebral protection was accomplished
with the use of FilterWire EZ (Boston Scientiﬁc), and
closed-cell stenting (Wallstent; Boston Scientiﬁc) was
used.
Postoperative (30-day) outcome was analyzed in
terms of:
d Stroke, clinically evaluated by the neurologist (accord-
ing to the National Institutes of Health Stroke Scale15)
and with a new acute ischemic or hemorrhagic lesion
identiﬁed by a cerebral CT scan with >24-hour
disability;
d TIA, also evaluated clinically by an independent in-
hospital neurologist as transient focal neurologic deﬁcit
with complete resolution within 24 hours, without
new ischemic lesion on the cerebral CT scan, per-
formed both immediately after the event and 24 hours
later.7 All patients with suspected postoperative TIA or
stroke were evaluated by duplex ultrasound to disclose
possible technical problems; in such a case, or in the
case of doubtful interpretation, contrast-enhanced
CT scan or surgical exploration was performed
immediately;
Table II. Timing and duration of postoperative cerebral events after carotid revascularization
Postoperative events
Timing Duration
<24 hours,
No. (%)
2-7 days,
No. (%)
2-4 weeks,
No. (%)
Permanent,
No. (%)
Improvement,
No. (%)a
Resolution,
No. (%)
Stroke (n ¼ 29) 23 (80) 3 (10) 3 (10) 9 (32) 10 (34) 10 (34)
CEA (n ¼ 14) 11 (80) 1 (7) 2 (14) 5 (36) 6 (43) 3 (21)
CAS (n ¼ 15) 12 (80) 2 (13) 1 (7) 4 (27) 4 (27) 7 (46)
<1 hour 1-6 hours >6 hours
TIA (n ¼ 38) 29 (76) 9 (24) 0 (0) 27 (71) 11 (29) 0 (0)
CEA (n ¼ 10) 7 (70) 3 (30) 0 (0) 5 (50) 5 (50) 0 (0)
CAS (n ¼ 28) 22 (77) 6 (23) 0 (0) 22 (79) 6 (21) 0 (0)
CAS, Carotid artery stenting; CEA, carotid endarterectomy; TIA, transient ischemic attack.
aImprovement deﬁned as reduction of at least 50% National Institutes of Health Stroke Scale15 at 6 months after the neurological event.
Table III. Comparative evaluation of patient characteristics in the groups with no postoperative cerebral events,
stroke, and transient ischemic attack (TIA)
Clinical characteristics
Postoperative events
P value
No events
(n ¼ 1323),
No. (%)
Stroke
(n ¼ 29),
No. (%)
TIA
(n ¼ 38),
No. (%)
Mean age 6 SD, years 71.4 6 8.6 76.7 6 8.3a,b 73.3 6 3.3 .002
Male sex 862 (65.1) 15 (51.7) 21 (55.2) .09
Preoperative neurological symptoms 350 (26.4) 16 (55.1)a,b 6 (15.7) .001
Hypertension 1174 (90.2) 27 (93.1) 36 (92.3) .82
Dyslipidemia 699 (52.8) 16 (55.1) 21 (55.2) .87
Diabetes 366 (27.6) 8 (27.5) 12 (31.1) .85
Smoking 210 (15.8) 3 (10.3) 3 (7.8) .31
Coronary artery disease 400 (30.2) 8 (27.5) 13 (34.2) .82
Chronic obstructive pulmonary disease 214 (13.1) 4 (13.7) 9 (23.6) .42
Chronic renal failure 179 (13.5) 7 (24.1) 3 (7.8) .14
Postoperative myocardial infarction 9 (0.6) 0 (0) 0 (0) .85
CAS, Carotid artery stenting; CEA, carotid endarterectomy; SD, standard deviation.
Post hoc univariate analysis: aP < .05 compared with no events group; bP < .05 compared with TIA group.
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ican heart association16); and
d Death
Follow-up was obtained by subsequent clinical outpa-
tient visit or in-hospital readmissions.
Statistical analysis. Continuous variables are expressed
as mean 6 standard deviation and frequencies by percent-
ages. Analyses of the differences between the two groups
were performed with use of the c2 test for categorical vari-
ables and unpaired Student t-test for continuous variables.
To compare more than two variables, the analysis of vari-
ance test with post hoc Bonferroni analysis was performed.
Factors affecting the long-term mortality rates were eval-
uated by unadjusted Cox analysis and subsequently
adjusted for signiﬁcant variables (or P < .10) by means of a
Cox proportional hazards model expressed by hazard ratio
(HR) and 95% conﬁdence interval (CI). Long-term sur-
vival for patients with postoperative TIA, stroke, or no
cerebral event was calculated by life tables (Kaplan-Maierwith log-rank evaluation). A value of P # .05 (two-tailed)
was considered to be signiﬁcant. The statistical tests were
performed with the use of SPSS 13.0 for Windows (SPSS,
Chicago, Ill).
RESULTS
Patient characteristics and carotid revascularization
outcomes. In a period of 8 years, 1390 carotid revascular-
izations (CEA, n ¼ 868 [62.4%]; CAS, n ¼ 522 [37.6%])
were performed. Table I summarizes the overall charac-
teristics of the entire population examined. There were 38
(2.7%) postoperative TIAs and 29 (2.0%) postoperative
strokes. Most postoperative events occurred in the ﬁrst
24 hours after the revascularization (80% of strokes and
76% of TIAs), as shown in Table II.
CEA and CAS had a similar incidence of postoperative
stroke (1.2% vs 2.8%; P ¼ .12), but TIA was signiﬁcantly
more frequent after CAS compared with CEA (5.3% vs
1.2%; P < .001). Preoperative neurological symptoms
were more frequent in patients with postoperative stroke
Fig 1. Life table (Kaplan-Maier analysis) of survival in patients
with postoperative transient ischemic attack (TIA), stroke, and no
neurological complications.
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no neurological events. Similarly, patients who had a post-
operative stroke were signiﬁcantly older compared with pa-
tients with postoperative TIA or no neurological events.
Clinical characteristics of patients with postoperative TIA,
stroke, or no cerebral events are reported in Table III.
Primary end point: Survival of patients with post-
operative TIA, stroke, or no neurological complica-
tions. The mean follow-up was 52.9 6 15.6 months. No
patients were lost to follow-up. Overall survival at
60 months was 95.5 6 0.07%.
By Kaplan-Maier analysis with the log-rank test,
patients with postoperative stroke or TIA showed lower
5-year survival compared with patients with no postopera-
tive cerebral neurological events (68.2 6 14.4% vs 97.4 6
0.6%; P ¼ .03; and 78.4 6 8.0% vs 97.4 6 0.6%; P < .001,
respectively; Fig 1). There was no signiﬁcant difference in
long-term mortality rates in comparing patients with post-
operative TIA and stroke (P ¼ .61).
At unadjusted Cox analysis CEA was a protective factor
for 5-year mortality, whereas age >80 years, preoperative
neurological symptoms, dyslipidemia, coronary artery dis-
ease, chronic renal failure and postoperative TIA, stroke,
and myocardial infarction were associated with higher risk
of 5-year mortality. By adjusted Cox model analysis, both
postoperative stroke and TIA were independently associ-
ated with a higher risk of 5-year mortality (HR, 3.87;
95% CI, 1.13-13.19; and HR, 3.10; 95% CI, 1.01-9.72,
respectively; Table IV). Similarly, age >80 years, chronic
renal failure, and postoperative myocardial infarction
remained independently associated with a higher risk of
5-year mortality (HR, 2.07; 95% CI, 1.41-4.90; P ¼ .01;
HR, 2.54; 95% CI, 1.04-6.19; P ¼ .04; and HR, 4.33;
95% CI, 2.74-23.79; P ¼ .04, respectively; Table IV).Secondary end point: Survival of patients with
postoperative TIA, stroke, or no neurological compli-
cations according to preoperative neurological symp-
toms. Preoperative asymptomatic patients who had a
postoperative TIA or stroke had lower 5-year survival
compared with patients without a postoperative neuro-
logical event (76.9 6 9.3, 66.7 6 16.1, and 98.3 6 0.6;
P ¼ .001, respectively; Fig 2). Differently, the 5-year sur-
vival was not signiﬁcantly inﬂuenced by postoperative
neurological course in preoperatively symptomatic patients
(TIA, 83.3 6 15.2%; stroke, 63.2 6 26.0%; no events,
95.3 6 1.4%; P ¼ .13; Fig 3).
DISCUSSION
Our data show a negative effect of postoperative TIA
on long-term survival after carotid revascularization. Simi-
larly to patients with postoperative stroke, those with post-
operative TIA showed higher long-term mortality rates
compared with patients with no postoperative neurological
complications. Patients with TIA and stroke showed a
similar mortality rate in the follow-up, suggesting that their
impact on survival is similar. By Cox analysis, both TIA and
stroke are independent risk factors for late death, together
with age, chronic renal failure, and postoperative myocar-
dial infarction. As secondary end points, we analyzed the
impact on long-term mortality rates of postoperative TIA
or stroke according to other factors. TIA and stroke were
associated with higher late mortality rates in patients who
were neurologically asymptomatic before surgery. Patients
who were preoperatively symptomatic had similar late mor-
tality rates regardless of the onset of new postoperative
symptoms. Thus, it is apparent that cerebral events, TIA,
and stroke affect the patient’s long-term survival, indepen-
dent of the timing of their onset. However, given the
low sample size, the latter analysis can be affected by a
type II error.
The inﬂuence of postoperative stroke on late survival
has been scarcely investigated in the literature; a recent
paper from Simons et al,10 reporting 1- and 5-year mortal-
ity rates of patients with postoperative stroke and myocar-
dial infarction, showed a signiﬁcantly higher late mortality
rate of these two groups compared with patients with no
postoperative complications (stroke HR, 2.7; myocardial
infarction HR, 2.8). These results are important in the
analysis of the impact of carotid revascularization complica-
tions on long-term mortality, particularly in the compari-
son between CEA and CAS, which show different rates
of neurologic events and myocardial infarction occurrence.
Although the long-term effect of postoperative
myocardial infarction has been carefully evaluated, the
last RCTs5,6 on carotid revascularization did not consider
TIA rate in their postoperative outcomes.6 Postoperative
TIAs are usually depicted in approximately 2% to 5% of
CAS and 0.5% to 1% in CEA,1,17-19 and new cerebral le-
sions are frequently found after both CAS and CEA by
diffusion-weighted magnetic resonance (50% and 17%,
respectively), even if asymptomatic in more than 80% of
cases.20,21 These results conﬁrm that microembolism
Table IV. Cox model hazard ratio (HR) for risk of mortality
Unadjusted Adjusted
HR 95% CI Sig. HR 95% CI Sig.
Clinical characteristics
CEA 0.17 0.89-0.35 .001 0.44 0.18-1.09 .08
Age >80 years 3.58 1.79-7.15 .001 2.07 1.41-4.90 .01
Male sex 0.65 0.30-1.39 .27
Preoperative neurological symptoms 1.85 0.92-3.73 .08 1.45 0.63-3.32 .37
Hypertension 0.53 0.18-1.52 .24
Dyslipidemia 1.18 0.91-3.59 .08 2.04 0.88-4.71 .09
Diabetes 0.85 0.41-1.75 .66
Smoking 2.18 0.66-7.15 .19
Coronary artery disease 2.51 1.27-4.97 .01 1.55 0.64-3.72 .32
Chronic obstructive pulmonary disease 1.28 0.49-3.31 .61
Chronic renal failure 3.85 1.89-7.84 .001 2.54 1.04-6.19 .04
Postoperative complications
Myocardial infarction 7.66 2.33-25.18 .001 4.33 2.74-23.79 .04
Stroke 3.48 1.34-9.03 .01 3.87 1.13-13.19 .03
TIA 4.61 1.99-10.68 .001 3.10 1.01-9.72 .04
CEA, Carotid endarterectomy; CI, conﬁdence interval; Sig., signiﬁcance, P # .05; TIA, transient ischemic attack.
Fig 2. Life table (Kaplan-Maier analysis) of survival in patients
with postoperative transient ischemic attack (TIA), stroke, or no
neurological complications in patients without preoperative
neurological symptoms.
Fig 3. Life table (Kaplan-Maier analysis) of survival in patients
with postoperative transient ischemic attack (TIA), stroke, or no
neurological complications in patients with preoperative neuro-
logical symptoms.
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zation and is a possible cause of TIA.
Although the effect of TIA after carotid revasculariza-
tion has not been considered in most studies, its effect on
the general population survival is well known. The PRISM
study, evaluating more than 22,000 patients, showed an
increased mortality rate in patients with TIA (3.5%, 13%,
and 20% at 1-, 5-, and 9-year follow-up, respectively)
compared with the expected survival of the general popula-
tion.22 Similarly, the Dutch TIA Trial showed 60%mortality at 10 years in patients who had a TIA.23 There
is a variety of possible TIA causes in the general
populationdsuch as cardiac rhythm alteration or great ves-
sels atherosclerosisdthat can be a cause of late death;
differently, TIAs after carotid revascularization are primar-
ily associated with intraprocedural or periprocedural embo-
lization. The majority of TIAs, in our study, occurred in
the CAS group. A plausible explanation for this is a greater
burden of atherosclerosis involvement (eg, aortic arch and
proximal brachiocephalic vessels) in these patients, with
JOURNAL OF VASCULAR SURGERY
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operative TIA may be interpreted as a marker for late
death. Although of different origin, the TIA effect on
long-term mortality is similar in the general population
and in patients submitted to carotid revascularization: as
a matter of fact, the 78% 5-year survival of our study com-
pares well with the 58% to 87% of the cohort studies in the
general population.22,23 Therefore, TIA can be considered
an indicator of clinical impairment independent of its path-
ogenesis, as conﬁrmed from our analysis in which, before
surgery, symptomatic patients had similar long-term
mortality rate regardless of the onset of other post-
operative events.
The low sample size of our study did not allow us to
perform an analysis to compare CEA and CAS in terms
of long-term mortality rates, which is beyond the aim of
this study.
The analysis of the risk factor for mortality conﬁrmed
also the inﬂuence of age and renal function on long-term
mortality, as shown in the Carotid Artery Revascularization
and Endarterectomy Registry,24 in which there was a high
risk of death, stroke, and myocardial infarction in patients
with chronic renal failure. Myocardial infarction diagnosis
was very selective in our patients and included at least
two parameters of chest pain, electrocardiographic modiﬁ-
cations, and troponine serum level increase, as suggested by
the American Heart Association deﬁnition16; nevertheless,
postoperative myocardial infarction was associated with a
higher risk of long-term mortality, as previously described
in CREST8 and in the study of Simons et al,10 in which
criteria for myocardial infarction diagnosis were more
extensive.
Limitations of our study were related to the low
number of postoperative events, which reduces the statis-
tical power of the analysis and did not allow an accurate
analysis of subgroups. As a matter of facts, we were un-
able to compare CEA and CAS in patients with postop-
erative neurological events and to analyze other factors
such as the timing of revascularization or the presence
of cerebral lesions.25 Although our long-term survival
may appear exceedingly higher compared with other se-
ries in the literature,10 there may be a variety of reasons
to explain it, including a very high incidence of asymp-
tomatic patients treated, the tight follow-up with timely
cardiologic workout, and the long life expectancy of
our population. Moreover, the impact of long-term sur-
vival on the ﬁnal result is irrelevant because patients
with and without postoperative complications were
equally inﬂuenced by it.
CONCLUSIONS
Although often underreported in the analysis of carotid
revascularization performance, TIAs are, together with
stroke, signiﬁcant events with important effects on long-
term mortality. Their incidence should be carefully
analyzed in the postoperative outcome of any trial evalu-
ating the performance of different revascularization
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